MovDisordV3, Ncbi, Merge, bibRecord, 000F61

Ecstasy use-Parkinson's disease link tenuous.

Identifieur interne : 000F61 ( Ncbi/Merge ); précédent : 000F60; suivant : 000F62

Ecstasy use-Parkinson's disease link tenuous.

Auteurs : Lisa Jerome ; Rick Doblin ; Michael Mithoefer

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.

RBID : pubmed:15389978

English descriptors

KwdEn :
- Administration, Oral, Adrenergic Uptake Inhibitors (toxicity), Dose-Response Relationship, Drug, Hallucinogens (toxicity), Humans, Injections, Subcutaneous, N-Methyl-3,4-methylenedioxyamphetamine (toxicity), Parkinson Disease, Secondary (chemically induced), Risk.
MESH :
- chemical , toxicity : Adrenergic Uptake Inhibitors, Hallucinogens, N-Methyl-3,4-methylenedioxyamphetamine.
- chemically induced : Parkinson Disease, Secondary.
- Administration, Oral, Dose-Response Relationship, Drug, Humans, Injections, Subcutaneous, Risk.

DOI: 10.1002/mds.20223
PubMed: 15389978

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003327
to stream PubMed, to step Curation: 003327
to stream PubMed, to step Checkpoint: 003477

Links to Exploration step

pubmed:15389978

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ecstasy use-Parkinson's disease link tenuous.</title>
<author><name sortKey="Jerome, Lisa" sort="Jerome, Lisa" uniqKey="Jerome L" first="Lisa" last="Jerome">Lisa Jerome</name>
</author>
<author><name sortKey="Doblin, Rick" sort="Doblin, Rick" uniqKey="Doblin R" first="Rick" last="Doblin">Rick Doblin</name>
</author>
<author><name sortKey="Mithoefer, Michael" sort="Mithoefer, Michael" uniqKey="Mithoefer M" first="Michael" last="Mithoefer">Michael Mithoefer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15389978</idno>
<idno type="pmid">15389978</idno>
<idno type="doi">10.1002/mds.20223</idno>
<idno type="wicri:Area/PubMed/Corpus">003327</idno>
<idno type="wicri:Area/PubMed/Curation">003327</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003477</idno>
<idno type="wicri:Area/Ncbi/Merge">000F61</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Ecstasy use-Parkinson's disease link tenuous.</title>
<author><name sortKey="Jerome, Lisa" sort="Jerome, Lisa" uniqKey="Jerome L" first="Lisa" last="Jerome">Lisa Jerome</name>
</author>
<author><name sortKey="Doblin, Rick" sort="Doblin, Rick" uniqKey="Doblin R" first="Rick" last="Doblin">Rick Doblin</name>
</author>
<author><name sortKey="Mithoefer, Michael" sort="Mithoefer, Michael" uniqKey="Mithoefer M" first="Michael" last="Mithoefer">Michael Mithoefer</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Adrenergic Uptake Inhibitors (toxicity)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Hallucinogens (toxicity)</term>
<term>Humans</term>
<term>Injections, Subcutaneous</term>
<term>N-Methyl-3,4-methylenedioxyamphetamine (toxicity)</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Risk</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en"><term>Adrenergic Uptake Inhibitors</term>
<term>Hallucinogens</term>
<term>N-Methyl-3,4-methylenedioxyamphetamine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Dose-Response Relationship, Drug</term>
<term>Humans</term>
<term>Injections, Subcutaneous</term>
<term>Risk</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15389978</PMID>
<DateCreated><Year>2004</Year>
<Month>11</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>02</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>19</Volume>
<Issue>11</Issue>
<PubDate><Year>2004</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ecstasy use-Parkinson's disease link tenuous.</ArticleTitle>
<Pagination><MedlinePgn>1386</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jerome</LastName>
<ForeName>Lisa</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Doblin</LastName>
<ForeName>Rick</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mithoefer</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018759">Adrenergic Uptake Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006213">Hallucinogens</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>KE1SEN21RM</RegistryNumber>
<NameOfSubstance UI="D018817">N-Methyl-3,4-methylenedioxyamphetamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Mov Disord. 2003 Nov;18(11):1378-81</RefSource>
<PMID Version="1">14639685</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000284">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018759">Adrenergic Uptake Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006213">Hallucinogens</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007279">Injections, Subcutaneous</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018817">N-Methyl-3,4-methylenedioxyamphetamine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010302">Parkinson Disease, Secondary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>2</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15389978</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20223</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Doblin, Rick" sort="Doblin, Rick" uniqKey="Doblin R" first="Rick" last="Doblin">Rick Doblin</name>
<name sortKey="Jerome, Lisa" sort="Jerome, Lisa" uniqKey="Jerome L" first="Lisa" last="Jerome">Lisa Jerome</name>
<name sortKey="Mithoefer, Michael" sort="Mithoefer, Michael" uniqKey="Mithoefer M" first="Michael" last="Mithoefer">Michael Mithoefer</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F61 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000F61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15389978
   |texte=   Ecstasy use-Parkinson's disease link tenuous.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15389978" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Ecstasy use-Parkinson's disease link tenuous.

Ecstasy use-Parkinson's disease link tenuous.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki